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ABSTRACT 
This study was aimed to formulate and evaluate solid dispersion containing ivermectin to improve solubility. Ivermectin is BCS 
(Biopharmaceutical classification system) class-II drug, which has high permeability and low water solubility (0.005mg/ml) which is 
responsible for its poor dissolution rate and ultimately leads to variable absorption. Solid dispersion with Gelucire (44/14) has the 
ability to improve dissolution of poor water soluble drugs. So, solid dispersion ivermectin with Gelucire 44/14 was prepared to 
enhance the solubility and was further evaluated for different parameters such as assay, wettability, DSC, FT-IR, dissolution study. 
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INTRODUCTION: 
Helminthiasis is the type of intestinal tract infection. 
Sometimes they may involve with other organs. The 
human body is with a parasitic worm such as 
roundworms and pinworms. The worms are usually 
present only in the intestinal tract. The severity of 
symptoms is classified by the type of worm and the part 
of the body infected. Ivermectin is the medication that is 
effective against many types of parasites. It is used to 
treat- Helminthiasis, Head lice; Scabies, Lymphatic 
filariasis, River blindness and Strongyloidiasis. 
Ivermectins are macro cyclic lactones derivatives
1
. It is 
derived from the bacterium Streptomycin avermitilis. 
Ivermectin kills by interfering with nervous 
system and muscle function, in particular by enhancing 
inhibitory neurotransmission. 3.0 mg and 6.0 mg tablets 
of ivermectin are available as marketed preparations
2
. 
Solid dispersion is defined as one or more active 
ingredients in an inert carrier or matrix at solid state 
prepared by the fusion-solvent or melting-solvent 
method. A product formed by converting a fluid drug-
carrier combination to the solid state
3
. Solid dispersion 
defines the texture of two different parts. One is the 
water soluble carrier and another is water in-soluble 
(polar) compounds. A carrier it can be either crystalline 
or amorphous in nature. They are based according to 
their drug molecular structure
4
. 
MATERIALS AND METHODS: 
Materials 
Ivermectin, Gelucire 44/14, Distilled Water, Aspartame, 
Methanol, Hydrochloric acid, Lactose, HPMC 
(hydroxypropyl methylcellulose), SSG (sodium starch 
glycolate), MCC (microcrystalline cellulose), 
Magnesium Stearate, Talc. 
Methods 
For preparation of solid dispersion: Different methods 
involves physical mixture, melting, kneading  
method, lyophilization, solvent evaporation, melt 
agglomeration process, extruding method, spray drying 
technology, use of surfactant, electro static spinning 
method and super critical fluid technology
5
. 
Physical Mixing 
Physical mixing method of Gelucire 44/14 with drug is 
prepared by geometric mixing of   drug & carrier 
respectively without applying pressure. An excess 
quantity of drug & carrier is taken in a glass mortar and 
mix for 20 minutes. 
Melting Method 
In Melting method the carrier Gelucire 44/14 is 
dissolved at 40
0
c. After the melting process, add drug. 
They are proper miscible of mixture. Immediately the 
mixture is cooled in freezing point. or at room 
temperature. After cooling the samples they were 
scrapped out. And dried powder is passes through sieve 
no 100#. 
Kneading Method 
Verma et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2017; 7(7):15-17                       
ISSN: 2250-1177                                                                                [16]                                                                             CODEN (USA): JDDTAO 
Solid dispersion by Kneading method is prepared by 
symmetrical mixing of drug with Gelucire 44/14. After 
mixing they were kneaded with appropriate ratio of 
solvent’s fusion to get and extent with a pasty 
consistency, which is dried in hot air oven at 45˚ to 
50˚C. The dried powder is passes through sieve no 100#. 
Lyophilization Technique 
In lyophilization process, the matrix & drug are 
dissolved in suitable solvent. After the geometric mixing 
of solution they are cooled& freeze dried in Vir-Tis 
Benchtop K lyophilizer (freeze drier) to 24 hrs. After 
lyophilization, get % yield amorphous powder. The 
dried solid dispersions were sieved through 100#. 
Characterization of solid dispersion 
Prepared solid dispersion can be characterized by 
differential scanning calorimetry (DSC) analysis, 
infrared (IR) analysis, wettability study, in-vitro 
dissolution study and effect of different formulation 
variables on various evaluation parameters
6
. 
Formulation of tablets using solid dispersion 
Tablets were formulated using solid dispersion 
containing equivalent quantity of 3 mg of Ivermectin by 
different techniques like (I) Physical mixing, (II) 
Melting method, (III) Kneading method, and (IV) 
Lyophilization. Plain tablet of Ivermectin (3mg) without 
Gelucire 44/14 was also prepared for comparison in the 
dissolution behaviour. All these tablet formulations were 
prepared using direct compression techniques with 
necessary excipients shown in table 1.  
 
Table 1: Excipients used in tablets containing plain Ivermectin, and with solid dispersion 
Excipients Plain Ivermectin Tablet (mg) Tablet with Ivermectin & solid dispersion(mg) 
Drug 3 33 
SSG 10 10 
MCC 20 20 
Magnesium stearate 2 2 
Talc 2 2 
Aspartame 5 5 
Menthol 2 2 
Lactose Uptoq.s. Uptoq.s. 
Total 300 300 
 
Characterization of tablets 
All these tablet formulations should be evaluated by 
various parameters such as size, shape, weight variation, 
hardness, friability, thickness, drug content, 
disintegration and in-vitro dissolution study. 
RESULT AND DISCUSSION: 
Table 2: Evaluation parameters of MDT tablet prepared 
using solid dispersion by melting method 
Parameter Value 
Size-Diameter 7.2 mm 
Shape Round 
Color White 
Thickness 4 mm 
Hardness 4.5 Kg/cm
2
 
Weight variation 275.6 mg 
Drug content 96.25 % 
Disintegration time 3-4 min 
 
In-vitro dissolution study of tablet formulation 
In-vitro dissolution study of tablet formulation was 
carried out in 0.1 N HCland presented in Figure 1. 
From this dissolution studies, it can be seen that the 
tablets prepared using solid dispersion by melting 
method showed highest cumulative % drug release 
(100% in both 0.1 N HCL)in comparison of plain 
Ivermectin. The tablets prepared using solid dispersion 
by other methods like physical mixing, kneading 
method, and lyophilization also showed in improvement 
of drug release in comparison to tablets prepared with 
plain Ivermectin. All these tablet formulations showed 
the maximum drug release in 90 minutes. Hence, 
melting method formulation was found the best 
formulation which gave highest % drug release at the 
end of 105mins. 
 
Figure 1: Dissolution profile MDT tablet of plain Ivermectin and PM, MM, KN & LY in 0.1 N HCL. 
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Table 3: % CDR of Tablet formulations in 0.1 N HCL in dissolution 
Time 
(min) 
% CDR of Tablet formulations 
Ivermectin PM MM KN LY 
15 6.45 48.92 60.22 53.76 50.00 
30 7.12 68.72 64.65 77.26 62.29 
45 8.33 77.60 78.82 84.87 77.49 
60 10.65 82.33 90.02 87.69 83.89 
75 11.39 89.82 96.58 87.11 87.59 
90 13.22 92.58 99.47 89.81 93.00 
105 14.00 93.22 100.77 91.45 94.72 
 
CONCLUSION: 
After optimizing the ratio of drug and carrier (1:10 
%w/w) by phase solubility studies, Ivermectin solid 
dispersion was successfully prepared by different 
methods like physical mixture. These solid dispersions 
confirm the entrapment of Ivermectin in the Gelucire 
44/14 by DSC and FTIR studies. All prepared solid 
dispersion of Ivermectin showed improvement in the 
Wettability and dissolution profile of Ivermectin. 
Highest improvement in the in-vitro dissolution profile 
was obtained in the solid dispersion prepared by melting 
method. Tablet formulation prepared using solid 
dispersions by melting method showed highest 
improvement in the dissolution profile in comparison to 
other solid dispersions as well as plain Ivermectin. 
Finally it can be concluded that poor dissolution profile 
of water insoluble Ivermectin can be overcome by 
preparing its solid dispersion with Gelucire 44/14.  
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